ANALYSIS OF ANTIHYPERGLYCEMIC DRUG PRESCRIPTIONS FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS IN THE ARKHANGELSK REGION


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Introduction. In modern society, the incidence of type 2 diabetes mellitus (DM-2) has reached pandemic levels. In 2017, a total of 425 million diabetic patients were registered; 90% of them were diagnosed with DM-2. Therefore, it is very relevant to analyze drug prescriptions for these patients and the possibility of their optimization for correcting the glycemic profile of patients with this disease. Objective: to analyze the prescriptions of antihyperglycemic agents used in the treatment of DM-2 at the regional level (in case of the Arkhangelsk Region) in conformity of drug prescriptions to the standard and algorithm for providing medical care to these patients. Material and methods. The investigation was performed using data from the federal registry of patients with diabetes mellitus. A sample included data on 16,218 patients aged 30 to 70 years who lived in the Arkhangelsk Region and were diagnosed with DM-2. Results. An analysis of the Federal Register data showed that DM-2 was twice more common in females than in males. There was a dramatic increase in the number of DM-2 patients over the age of 60 years. Conclusion. Evaluation of drug prescriptions revealed that monotherapy with antihyperglycemic drugs of the biguanide group was most commonly used.

全文:

受限制的访问

作者简介

Tatyana Orlova

North State Medical University

Email: tsorlova@icloud.com
Assistant, Department of Pharmacy and Pharmacology 51, Troitsky Prospect, Arkhangelsk 163000, Russian Federation

Olga Buyuklinskaya

North State Medical University

Email: obfarm@mail.ru
Associate Professor, Doctor of Medical Sciences, Head of the Department of Pharmacy and Pharmacology 51, Troitsky Prospect, Arkhangelsk 163000, Russian Federation

Ekaterina Loskutova

Peoples' Friendship University of Russia

Email: ekaterinaloskuttova@gmail.com
Doctor of Pharmaceutical Sciences, Professor, Head of the Department of Management and Economics of Pharmacy, Faculty of Medicine 6, Miklukho-Maklai St., Moscow 117198, Russian Federation

Ivan Bojko

North State Medical University

Email: bloodwolf.ivan@gmail.com
Assistant, Department of Pharmacy and Pharmacology 51, Troitsky Prospect, Arkhangelsk 163000, Russian Federation

Aleksandr Plakuev

North State Medical University

Email: plakuev@rambler.ru
Candidate of Medical Sciences, Associate Professor of the Department of Family Medicine and Internal Medicine 51, Troitsky Prospect, Arkhangelsk 163000, Russian Federation

参考

  1. Дедов И.И, Шестакова М.В., Викулова О.К. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета. Сахарный диабет, 2017; 20 (1): 13-41. https://doi.org/14341/DM8664
  2. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Клинические рекомендации. Под ред. И.И. Дедова, М.В. Шестаковой. Сахарный диабет, 2017;20(1S): 1-112. https://doi.org/10.14341/DM20151S1-112
  3. Тажиева А.Е., Резник В.Л., Иванов С.В., Гржибовский А.М. Распространенность осложнений сахарного диабета 2 типа и сопутствующих заболеваний в городе Алма-Аты Республики Казахстан в 2012-2016 г.г. Экология человека, 2017; 10: 57-64.
  4. American Diabetes Association.Diagnosisand Classification of Diabetes Mellitus. DiabetesCare 34.Suppl 1 (2011): 62-9.
  5. Федеральная служба государственной статистики; Численность и состав населения. [Электронное издание]. Режим доступа: http://arhangelskstat.gks.ru/wps/wcm/connect/rosstat_ts/arhangelskstat/ru/statistics/population/
  6. Дедов И.И., Шестакова М.В., Викулова О.К., Железнякова А.В., Исаков М.А. Сахарный диабет в Российской Федерации: распространенность, заболеваемость, смертность, параметры углеводного обмена и структура сахароснижающей терапии по данным Федерального регистра сахарного диабета, статус 2017 г. Russian Association of Endocrinologists, 2018 Received: 24.05.2018. Accepted: 10.06.2018.
  7. Zinman B., Skyler J. S., Riddle M.C., Ferrannini E. Diabetes Research and Care Through the Ages, Diabetes Care Oct 2017, 40 (10) 1302-13.
  8. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015; 386, 743800.
  9. Riddle M.C., Herman W.H. The Cost of Diabetes Care - An Elephant in the Room. Diabetes Care, 2018; 41 (5): 929-32.
  10. Никонова Т.В. Современный алгоритм лечения сахарного диабета типа 2. Кому и как назначать комбинированные сахароснижающие препараты. Consilium Medicum, 2008; 9: 25-30.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2019